Related Experiment Video
Updated: Jun 23, 2025

07:35
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
1.6K
Knowledge Graph Neural Network With Spatial-Aware Capsule for Drug-Drug Interaction Prediction
IEEE Journal of Biomedical and Health Informatics
|June 25, 2024
Summary
This study introduces KGCNN, a novel graph neural network model for predicting drug-drug interactions (DDIs). KGCNN effectively captures spatial relationships in biomedical knowledge graphs, improving DDI prediction accuracy.
Area of Science:
- Computational chemistry
- Bioinformatics
- Artificial intelligence in medicine
Background:
- Predicting drug-drug interactions (DDIs) is crucial for drug development and patient safety.
- Graph neural networks (GNNs) show promise for DDI prediction but struggle with spatial relationships.
- Existing methods lack effective capture of higher-level features from neighboring nodes.
Purpose of the Study:
- To introduce KGCNN, a novel model for comprehensive DDI prediction.
- To address limitations in capturing spatial relationships and higher-level features in GNN-based DDI prediction.
- To leverage biomedical knowledge graphs (BKGs) for improved DDI prediction.
Main Methods:
- Developed KGCNN, a message-passing GNN framework with propagation and aggregation.
- Utilized a biomedical knowledge graph (BKG) to govern information propagation based on semantic relationships.
- Introduced a spatial-aware capsule aggregator to capture spatial relationships and higher-level features.
Main Results:
- KGCNN demonstrated superior performance in DDI prediction tasks.
- Experimental results on two datasets validated the model's effectiveness.
- The model achieved quantified performance improvements in predicting DDIs.
Conclusions:
- KGCNN effectively captures spatial relationships within BKGs for DDI prediction.
- The spatial-aware capsule aggregator enhances the representation of molecular interactions.
- KGCNN offers a superior approach for computational DDI prediction.
Related Concept Videos
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Quantitative Aspects of Drug-Receptor Interaction
972
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
972

